Article
SBT-272 improves TDP-43 pathology in the ALS motor cortex by modulating mitochondrial…
medRxiv · 2022 · Gautam, M.; Genc, B.; Helmold, B.; Ahrens, A.; Kuka, J.; Makrecka-Kuka, M.; Gunay, A.; Kocak, N.; Aguilar-Wickings, I. R.; Keefe, D.; Zheng, G.; Swaminathan, S.; Redmon, M.; Zariwala, H. A.; Ozdinler, P. H.
Key facts
| Title | SBT-272 improves TDP-43 pathology in the ALS motor cortex by modulating mitochondrial integrity, motility, and function |
|---|---|
| First author | Gautam, M.; Genc, B.; Helmold, B.; Ahrens, A.; Kuka, J.; Makrecka-Kuka, M.; Gunay, A.; Kocak, N.; Aguilar-Wickings, I. R.; Keefe, D.; Zheng, G.; Swaminathan, S.; Redmon, M.; Zariwala, H. A.; Ozdinler, P. H. |
| Journal | medRxiv |
| Published | Oct 10, 2022 |
| DOI | 10.1101/2022.10.04.510854 |
| Devices mentioned | BK110039, K103302, K183072, K231861, K241486, K832197, K832200, K934738, K981128 |
| Product codes mentioned | DMZ, DPM, FFX, GAP, NDS, OCW, PCA, GAA, KNW, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1